HealthQuill FDA clearance
cigarette smoke
Drugs Health Pharma

US drug regulator clears Qnovia’s nicotine inhaler for clinical testing

HQ Team October 7, 2024: The US Food and Drug Administration (FDA)has cleared Qnovia Inc’s nicotine inhaler RespiRx for clinical trial. The US.

Read More
A blood protein, called fibrin, which supports clotting, is responsible for switching on detrimental genes in Alzheimer’s disease and multiple sclerosis, researchers say.
Health Medical Pharma

FDA clears Abbott’s rapid blood test for concussion assessment

HQ  Team April 18, 2024: The Food and Drug Administration (FDA) has cleared Abbot’s i-STAT TBI cartridge for rapid assessment of mild traumatic.

Read More